|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Notice to Readers: National Vaccine Advisory Committee Workshop on Thimerosal in VaccinesThe National Vaccine Advisory Committee will sponsor a workshop on thimerosal in vaccines on August 11-12, 1999. The workshop will be held at the Lister Hill Auditorium on the National Institutes of Health campus, Bethesda, Maryland, and will review use of thimerosal in vaccines and its reduction and elimination from vaccines. Additional information is available from the National Vaccine Program Office, CDC, Mailstop A-11, 1600 Clifton Rd, N.E., Atlanta, GA 30333; telephone (404) 639-4450; or from the World-Wide Web, http://www.cdc.gov/od/nvpo/calendar/htm. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 7/22/99 |
|||||||||
This page last reviewed 5/2/01
|